Novel dosage and formulation for inhalation comprising aclidinium

摘要

The invention relates to a pharmaceutical composition for inhalation comprising aclidinium in the form of a dry powder of a pharmaceutically acceptable salt in admixture with a pharmaceutically acceptable dry powder carrier.The composition comprises a dose of aclidinium equivalent to about 322 µg of aclidinium free base and/or a metered nominal dose equivalent to about 140 µg of aclidinium bromide.A method of treating respiratory conditions using the formulation disclosed and a calibrated dry powder inhaler device are also provided.